Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/26/21 → 6/28/23 |
Funding
- Janssen Vaccines and Prevention BV: $1,313,084.00
Covid 19: A Randomized, Double-blind, Phase 2 Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Ad26.COV2.S Administered as Booster Vaccination in Adults 18 Years of Age and Older Who Have Previously Received Primary Vaccination with Ad26
- Greenberg, Richard (PI)
- Caudill, Timothy (CoI)
- Simmons, Christopher (CoI)